Benzinga | Oct 8, 2020 05:45AM EDT

BTIG Initiates Coverage On Accelerate Diagnostics with Neutral Rating

BTIG analyst Mark Massaro initiates coverage on Accelerate Diagnostics (NASDAQ:AXDX) with a Neutral rating.